Princeton Global Asset Management LLC Has $32,000 Holdings in Cigna Group $CI

Princeton Global Asset Management LLC lifted its holdings in Cigna Group (NYSE:CI) by 115.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 97 shares of the health services provider’s stock after purchasing an additional 52 shares during the period. Princeton Global Asset Management LLC’s holdings in Cigna Group were worth $32,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of CI. Valeo Financial Advisors LLC lifted its stake in shares of Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares during the last quarter. Nuveen LLC acquired a new position in Cigna Group during the 1st quarter worth $727,905,000. Price T Rowe Associates Inc. MD lifted its position in Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. GQG Partners LLC lifted its position in Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after acquiring an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in Cigna Group by 38.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after acquiring an additional 457,052 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CI. Barclays boosted their target price on shares of Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Wells Fargo & Company boosted their target price on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 7th. Wolfe Research cut their target price on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Truist Financial set a $375.00 target price on shares of Cigna Group in a research report on Tuesday, September 2nd. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $369.89.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

Cigna Group Stock Performance

NYSE:CI opened at $307.42 on Wednesday. The firm’s 50-day moving average is $298.40 and its 200-day moving average is $307.80. Cigna Group has a 52-week low of $256.89 and a 52-week high of $350.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a market cap of $82.06 billion, a price-to-earnings ratio of 16.78, a PEG ratio of 0.90 and a beta of 0.45.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the previous year, the firm posted $6.72 EPS. The business’s revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.